Solving Industry Problems through Strategic Partnerships

Hydroemission works closely with industry leaders to identify wide-ranging solutions, based on repurposing innovative controlled release technology.

The driving forces and guiding principles behind the development of these new solutions are:

  • Reduction in labor requirements

  • Improvement in treatment efficacy

  • Decreased consumption of actives

  • Prevention of environmental pollution

  • Lowered resistance development in targeted organisms

  • Safer, easier to handle active ingredients

  • Protection of actives from environmental degradation (e.g. UV exposure)

  • Facilitation of new product and formulation development

  • Extension of the patent life for proprietary actives close to, or are at, their patent expiration dates

 

Hydroemission provides early stage manufacturing capabilities to its developmental partners for phased production and initial market penetration. Hydroemission then supports scaling-up of production through technology transfer and licensing to its partners, enabling them to produce the controlled release formulation in-house.

Sometimes the identified solution is sufficiently novel to qualify for a patent application. In those cases, Hydroemission is receptive to filing a joint patent with its partners, in territories where the partner has (or is expected to have) a market presence.

Scalable, Adaptable, Cost-Effective Systems

Controlled release technology is an approach based on materials science and with its roots in pharmaceuticals to dose active ingredients into the environment at predetermined rates and duration to bring about the desired treatment effects, without the use of machinery or equipment.

Hydroemission’s technological offerings span a multitude of controlled release delivery systems to cater to wide-ranging application requirements. Those currently offered are:

Biodegradable Controlled Release Matrix Tablets for Environmental Applications

Biodegradable Controlled Release Microparticles for Non-Medical Applications

Controlled Release Membrane Delivery System for Ambient Treatment Applications

Hydroemission’s controlled release delivery systems are characterised by the following unique features:

  • Flexible - They are able to encapsulate practically any actives, ranging from powders to gels or liquids, with up to an 80% payload. They also offer a high degree of release profile manipulation capability.

  • Non-invasive – Processing is carried out at ambient temperatures (20 – 30 °C) and pressures (5 – 50 psi), maintaining the integrity of the actives.

  • Cost-effective - They are produced using an innovative extrusion-based approach which reduces production costs.

  • Biodegradable – Controlled release matrixes and devices are biodegradable, to ensure complete compatibility with the application environment.

  • Scalable – Manufacturing processes and equipment are simple and cost effective, enabling quick and easy product scale-up.

© Hydroemission 2010. All Rights Reserved 

Hydroemission Corporation Pte Ltd, 6 Raffles Quay #16-01 Singapore 048580  email: SG@hydroemission.com 

  • linkedin